Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies
ClinicalTrials.gov study NCT02454270. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
ClinicalTrials.gov study NCT00307177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of SGR-1505 in Mature B-Cell Neoplasms
ClinicalTrials.gov study NCT05544019. IPD Sharing: NO. Countries: 8. Publications: 0.
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
ClinicalTrials.gov study NCT05263583. IPD Sharing: YES. Countries: 2. Publications: 0.
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
ClinicalTrials.gov study NCT04974216. IPD Sharing: NO. Countries: 2. Publications: 0.
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT07284433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
ClinicalTrials.gov study NCT02134262. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT07073833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
ClinicalTrials.gov study NCT04150497. IPD Sharing: NO. Countries: 2. Publications: 0.
17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
ClinicalTrials.gov study NCT00098488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
ClinicalTrials.gov study NCT00338494. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
ClinicalTrials.gov study NCT05106972. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CNS Prophylaxis in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02777736. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas
ClinicalTrials.gov study NCT02247609. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of ET190L1 ARTEMIS™ in Relapsed, Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT03415399. IPD Sharing: NO. Countries: 1. Publications: 0.
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
ClinicalTrials.gov study NCT06271057. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia
ClinicalTrials.gov study NCT02672501. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL
ClinicalTrials.gov study NCT07244406. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polat
ClinicalTrials.gov study NCT06734078. IPD Sharing: NO. Countries: 1. Publications: 0.
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
ClinicalTrials.gov study NCT05098613. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.